Zealand's Swinging Stock Maps the Weight-Loss Drug Market's Next Bet
Zealand, the biotech whose share price has become an informal gauge of sentiment across the weight-loss drug sector, is recording a visible shift in investor positioning. One of its experimental medicines has lost market…